Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.63 USD | +2.67% | +1.12% | -0.08% |
Apr. 17 | Sector Update: Health Care Stocks Mixed Wednesday Afternoon | MT |
Apr. 17 | Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise | MT |
Financials (USD)
Sales 2024 * | 3.39M | Sales 2025 * | 3.13M | Capitalization | 2.55B |
---|---|---|---|---|---|
Net income 2024 * | -170M | Net income 2025 * | -203M | EV / Sales 2024 * | 670 x |
Net cash position 2024 * | 285M | Net cash position 2025 * | 372M | EV / Sales 2025 * | 697 x |
P/E ratio 2024 * |
-13.3
x | P/E ratio 2025 * |
-11.9
x | Employees | 160 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.65% |
Latest transcript on Celldex Therapeutics, Inc.
1 day | +2.67% | ||
1 week | +1.12% | ||
Current month | -5.58% | ||
1 month | -5.67% | ||
3 months | -0.20% | ||
6 months | +60.97% | ||
Current year | -0.08% |
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +4.75% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 39.63 | +2.67% | 954,933 |
24-04-16 | 38.6 | -1.20% | 722,557 |
24-04-15 | 39.07 | -0.46% | 409,378 |
24-04-12 | 39.25 | -3.96% | 498,039 |
24-04-11 | 40.87 | +4.29% | 595,686 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.08% | 2.49B | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- CLDX Stock